13D/13G Filings - KalVista Pharmaceuticals Inc. (KALV)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
4:30 pm
Purchase
2020-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
Vivo Ventures VI LLC 1,383,179
5.900%
1,383,179increase
(New Position)
Filing
History
2021-02-08
10:25 am
Sale
2021-02-05 13G KalVista Pharmaceuticals, Inc.
KALV
FMR LLC 1,640,278
9.142%
-150,513decrease
(-8.40%)
Filing
History
2021-02-02
2:56 pm
Purchase
2020-12-31 13G KalVista Pharmaceuticals, Inc.
KALV
BlackRock Inc.
BLK
1,113,380
6.200%
1,113,380increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3